Details for 2019160124
Up to date per 02.04.2026
Actions
Details for 2019160124
Granted/Registered
European Patent
24.07.2019 A
23.04.2025 B1
06.08.2014
US
201462033679 P
C07D 401/14 20060101AFI20190327BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
No representatives present
Inventor
LUZZIO, Michael JosephNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
PAPILLON, JulienNovartis Institutes for BioMedical Research Inc. 250 Technology Square Cambridge, MA 02139US
VISSER, Michael ScottNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, MA 02131US
Information about Fees